(Q44210765)

30 November 2017

title

High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis (English)

1 reference

30 November 2017

2

1 reference

30 November 2017

4

Litzow MR

1 reference

30 November 2017

5

Gertz MA

1 reference

30 November 2017

3

Lacy MQ

1 reference

30 November 2017

Kumar S

1

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

Bone Marrow Transplantation

30 November 2017

published in

1 reference

30 November 2017

volume

28

1 reference

30 November 2017

issue

4

1 reference

30 November 2017

page(s)

381-385

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703155

30 November 2017

exact match

0 references

cites work

Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

Gastrointestinal angiographic findings in systemic amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

Amyloidosis--an unusual case of recurrent intestinal bleeding and sigmoid perforation: case report with review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

A clinical analysis of the course and prognosis of forty-two patients with amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

21 January 2018

Amyloidosis and the gut

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

Deposition of amyloid in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

Mechanism of factor X deficiency in systemic amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

Retroperitoneal amyloidosis, factor IX and X deficiency,and gastrointestinal bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

Gastric vascular ectasia in patients undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

Amyloidosis: a review of recent diagnostic and therapeutic developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

Intermediate-dose intravenous melphalan and blood stem cells mobilized with sequential GM+G-CSF or G-CSF alone to treat AL (amyloid light chain) amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

Abnormalities in thrombin-antithrombin pathway in AL amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

7 January 2021

Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

7 January 2021

Allogeneic bone marrow transplantation for systemic AL amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

7 January 2021

Allogeneic bone marrow transplantation for AL amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

7 January 2021

Gastrointestinal amyloid deposits in old age. Report on 110 consecutive autopsical patients and 98 retrospective bioptic specimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

7 January 2021

Gastrointestinal manifestations of amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

7 January 2021

Localized primary amyloidosis of the stomach presenting with gastric hemorrhage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

7 January 2021

Intestinal obstruction and gastrointestinal bleeding due to systemic amyloidosis in a woman with occult plasma cell dyscrasia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

7 January 2021

Primary systemic amyloidosis presenting with severe intestinal haemorrhage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

7 January 2021

Amyloidosis with factor X deficiency.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

7 January 2021

Acquired factor X and antithrombin III deficiency in a patient with primary amyloidosis and nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

7 January 2021

Incidence and outcome of overt gastrointestinal bleeding in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

7 January 2021

Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703155

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703155

1 reference

Dimensions Publication ID

30 November 2017

1034665660

0 references

1 reference